Product Images Budesonide And Formoterol Fumarate Dihydrate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Budesonide And Formoterol Fumarate Dihydrate NDC 53002-2666 by Rpk Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Counter Image 15 - 308708 rapihaler counter 15 (black;130;485)

Counter Image 15 - 308708 rapihaler counter 15 (black;130;485)

Counter Image 80 - 308710 rapihaler counter 80 (black;130;485)

Counter Image 80 - 308710 rapihaler counter 80 (black;130;485)

Figure 1 - figure1bodytext

Figure 1 - figure1bodytext

Figure 2 - figure2bodytext

Figure 2 - figure2bodytext

Figure 3 - figure3bodytext

Figure 3 - figure3bodytext

Figure 4 - figure4bodytext

Figure 4 - figure4bodytext

This is a graph showing the percent change from baseline in FEV (forced expiratory volume) over a period of 12 hours. It represents the first day of treatment with Budesonide and Formoterol Fumarate Dihydrate, with predose FEV readings for both medications. The final visit (EOT) shows the combination of Budesonide 160 mcg and Formoterol 4.5 mcg, with two inhalations taken twice daily. There is no information regarding the results or effectiveness of the medication.*

Figure 5 - figure5bodytext

Figure 5 - figure5bodytext

Figure 6 - figure6bodytext

Figure 6 - figure6bodytext

This is a chart that shows the percent change from baseline in pre-dose FEV for different medications and dosages. The medications include Budescnide and Formoterol Fumarate AL Dibydrato, Budesonide, Formotarol, Budesonide and Formoterol Fumarate Dihydrate MDI, and Flacebo. The dosages vary from 160 to 4.5 mcg, and the administration is two inhalations twice daily.*

Figure 7 - figure7bodytext

Figure 7 - figure7bodytext

This appears to be a chart showing the percent change from baseline in 1-hour post-dose FEV for different types of inhalations, including Budesonide and Formoterol Fumarate and a placebo. The values differ depending on the type of inhalation and the duration of treatment.*

budesonide structural formula - image 01

budesonide structural formula - image 01

structural fumarate - image 02

structural fumarate - image 02

Figure 1 - image 03

Figure 1 - image 03

The text describes parts of a "Counter" product including a canister for water inside, a mouthpiece, a strap, and a mouthpiece cover. There may be a diagram labeled "Figure 1" with these parts labeled.*

Figure 2 gray arrows - image 04

Figure 2 gray arrows - image 04

Figure 3 - image 05

Figure 3 - image 05

Figure 4 - image 06

Figure 4 - image 06

Figure 5 - image 07

Figure 5 - image 07

Label Image - lbl530022666

Label Image - lbl530022666

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.